Replenishing urease in dialysis systems using urease pouches
US-2015367060-A1 · Dec 24, 2015 · US
US11298447B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11298447-B2 |
| Application number | US-201916266193-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 4, 2019 |
| Priority date | Feb 4, 2019 |
| Publication date | Apr 12, 2022 |
| Grant date | Apr 12, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A carbon dioxide absorption medium. The absorption medium includes a plurality of hollow fibers and a plurality of binder particles. The hollow fibers have walls comprising a selectively permeable membrane that is configured to permit passage of gaseous carbon dioxide but not liquids. The plurality bind particles are dispersed between the hollow fibers and comprise an absorbent material configured to absorb gaseous carbon dioxide and to bind the carbon dioxide in a solid state.
Opening claim text (preview).
What is claimed is: 1. A carbon dioxide absorption medium comprising: a plurality of hollow fibers, each hollow fiber of the plurality having a proximal end, a distal end, a lumen extending between the proximal and distal ends, and a wall surrounding the lumen, the wall of each hollow fiber of the plurality comprising a membrane selectively permeable to gaseous carbon dioxide; and a plurality of binder particles dispersed between hollow fibers of the plurality, each binder particle of the plurality being configured to absorb gaseous carbon dioxide and to bind and to retain the carbon dioxide in a solid state. 2. The carbon dioxide absorption medium of claim 1 , wherein the membrane comprising the wall of each hollow fiber of the plurality comprises at least one polymer selected from the group consisting of cellulose acetate, cellulose triacetate, polyamide, polysulfone, polyethersulfone (PES), polyacrylonitrile (PAN), sulfonated polyacrylonitrile, polymethylmethacrylate (PmmA), and polymethylpentene (PMP). 3. The carbon dioxide absorption medium of claim 1 , wherein the wall of each hollow fiber of the plurality has an outer thickness ranging from about 5 μm to about 50 μm. 4. The carbon dioxide absorption medium of claim 1 , wherein the binder particles of the plurality have a maximum dimension ranging from about 100 μm to about 10,000 μm. 5. The carbon dioxide absorption medium of claim 1 , wherein the plurality of binder particles comprise at least one absorbent material selected from the group consisting of sodium oxide, sodium hydroxide, calcium oxide, calcium hydroxide, potassium hydroxide, lithium hydroxide, lithium peroxide, lithium carbonate, and lithium chloride. 6. A carbon dioxide absorption cartridge for removing carbon dioxide from the blood of a patient, the cartridge comprising: a housing having an inlet port and an outlet port and an internal cavity therebetween, the inlet port configured to fluidically receive blood from the patient and the outlet port configured to fluidically return filtered blood to the patient; and the carbon dioxide absorption medium of claim 1 disposed within the internal cavity of the housing. 7. The cartridge of claim 6 , wherein the membrane comprising the wall of each hollow fiber of the plurality comprises at least one polymer selected from the group consisting of cellulose acetate, cellulose triacetate, polyamide, polysulfone, polyethersulfone (PES), polyacrylonitrile (PAN), sulfonated polyacrylonitrile, polymethylmethacrylate (PmmA), and polymethylpentene (PMP). 8. The cartridge of claim 6 , wherein the wall of each hollow fiber of the plurality has an outer thickness ranging from about 5 μm to about 50 μm. 9. The cartridge of claim 6 , wherein the binder particles of the plurality have a maximum dimension ranging from about 100 μm to about 10,000 μm. 10. The cartridge of claim 6 , wherein the plurality of binder particles comprise at least one absorbent material selected from the group consisting of sodium oxide, sodium hydroxide, calcium oxide, calcium hydroxide, potassium hydroxide, lithium hydroxide, lithium peroxide, lithium carbonate, and lithium chloride. 11. The cartridge of claim 6 , wherein the internal cavity of the housing comprising a first partition and a second partition fluidically isolated from the first partition, wherein the proximal ends of the hollow fibers of the plurality extend into the first partition while the distal ends of the hollow fibers of the plurality and the plurality of binder particles reside within the second partition such that flow of blood through the housing is restricted to flow through the plurality of hollow fibers. 12. The cartridge of claim 6 , wherein the absorption medium removes carbon dioxide from the blood at a rate ranging from about 50 mL/min to about 100 mL/min as measured at about atmospheric pressure and at a temperature from about 35° C. to about 39° C. 13. The cartridge of claim 6 , wherein the blood flows through the absorption medium at a rates ranging from about 0.2 L/min to about 0.5 L/min. 14. A blood treatment system comprising: the carbon dioxide absorption cartridge of claim 6 ; a first blood flow pathway extending between a patient and the inlet port of the housing of the carbon dioxide absorption cartridge; and a second blood flow pathway extending between the outlet port of the housing of the carbon dioxide absorption cartridge and the patient. 15. The blood treatment system of claim 14 , further comprising: a pump configured to pump blood between the patient and the carbon dioxide absorption cartridge along the first and second blood flow pathways. 16. The blood treatment system of claim 14 , further comprising: a dialyzer along the first blood flow pathway or the second blood flow pathway and configured to perform hemodialysis. 17. A method for removing carbon dioxide from blood, the method comprising: transporting blood from a patient to a carbon dioxide absorption cartridge, the carbon dioxide absorption cartridge comprising: a housing having an internal cavity therein; and a carbon dioxide absorption medium disposed within the internal cavity of the housing, the carbon dioxide absorption medium comprising a plurality of hollow fibers, each hollow fiber of the plurality having a proximal end, a distal end, a lumen extending between the proximal and distal ends, and a wall surrounding the lumen, the wall of each hollow fiber of the plurality comprising a membrane selectively permeable to gaseous carbon dioxide and a plurality of binder particles dispersed between hollow fibers of the plurality, each binder particle of the plurality being configured to absorb gaseous carbon dioxide and bind the carbon dioxide in a solid state; moving the blood through the carbon dioxide absorption cartridge, thereby removing carbon dioxide from the blood; and transporting the blood from the carbon dioxide absorption cartridge to the patient, wherein neither a carrier fluid flow nor a sweep fluid flow is required for removing carbon dioxide from the blood of the patient. 18. The method of claim 17 , wherein the membrane comprising the wall of each hollow fiber of the plurality comprises at least one polymer selected from the group consisting of cellulose acetate, cellulose triacetate, polyamide, polysulfone, polyethersulfone (PES), polyacrylonitrile (PAN), sulfonated polyacrylonitrile, polymethylmethacrylate (PmmA), and polymethylpentene (PMP). 19. The method of claim 17 , wherein the wall of each hollow fiber of the plurality has an outer thickness ranging from about 5 μm to about 50 μm and the binder particles of the plurality have a maximum dimension ranging from about 100 μm to about 10,000 μm. 20. The method of claim 17 , wherein the plurality of binder particles comprise at least one absorbent material selected from the group consisting of sodium oxide, sodium hydroxide, calcium oxide, calcium hydroxide, potassium hydroxide, lithium hydroxide, lithium peroxide, lithium carbonate, and lithium chloride. 21. The method of claim 17 , wherein carbon dioxide is removed from the blood at a rate ranging from about 50 mL/min to about 100 mL/min. 22. The method of claim 17 , wherein blood flows through carbon dioxide absorption cartridge at a range ranging from about 0.2 L/min to about 0.5 L/min. 23. The cartridge of claim 6 , wherein neither a carrier fluid flow nor a sweep fluid flow is required for removing carbon dioxide from the blood of the pa
Two or more types of hollow fibres within one bundle or within one potting or tube-sheet · CPC title
Polyacrylonitrile · CPC title
by absorption (A61M1/3675 takes precedence) · CPC title
Adsorbents within the flow path · CPC title
Absorption or adsorption · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.